Diabetic foot disease is a serious and common complication of long-standing diabetes mellitus, representing a major cause of morbidity, hospital admissions, and lower-limb amputations worldwide. It arises from a complex interplay of peripheral neuropathy, peripheral arterial disease, infection, and impaired wound healing. Early diagnosis and coordinated multidisciplinary management are critical to limb salvage and patient survival. We report a case of an infected diabetic foot ulcer in a middle-aged man with poorly controlled type 2 diabetes mellitus. Comprehensive clinical assessment, microbiological evaluation, vascular imaging, and metabolic optimization guided a multimodal treatment strategy involving wound care, targeted antibiotic therapy, glycemic control, and surgical intervention. The patient achieved satisfactory wound healing with limb preservation. This case highlights the importance of early recognition, structured assessment, and team-based care in optimizing outcomes in diabetic foot disease.
Diabetic foot complications are among the most debilitating sequelae of diabetes mellitus, affecting approximately 15–25% of patients during their lifetime and accounting for up to 85% of diabetes-related amputations [1]. Peripheral neuropathy leads to loss of protective sensation, while peripheral arterial disease compromises tissue perfusion, predisposing patients to ulceration and infection. Once established, diabetic foot ulcers (DFUs) are challenging to treat and are associated with high rates of recurrence, amputation, and mortality [2].
The management of diabetic foot disease requires early diagnosis, accurate assessment of infection and ischemia, and prompt initiation of evidence-based therapy. International guidelines emphasize the role of multidisciplinary foot care teams in reducing complications and improving limb salvage rates [3]. This case report describes the clinical presentation, diagnostic workup, and integrated management of an infected diabetic foot ulcer, illustrating key principles of contemporary care.
A 56-year-old man presented to the surgical outpatient department with a non-healing ulcer over the plantar aspect of his right foot for six weeks. He reported progressive swelling, foul-smelling discharge, and increasing pain over the past ten days. The patient had a 12-year history of type 2 diabetes mellitus, with irregular follow-up and suboptimal glycemic control. He also had a history of hypertension but no known coronary artery disease.
There was no history of trauma, fever, or prior foot ulcers. The patient admitted to walking barefoot indoors and had not received prior diabetic foot education.
On general examination, the patient was afebrile and hemodynamically stable. Pallor was absent, and systemic examination was unremarkable. Local examination of the right foot revealed a 3 × 3 cm ulcer over the plantar surface at the head of the first metatarsal. The ulcer had irregular margins, a necrotic base, and purulent discharge with surrounding erythema and induration.
Peripheral sensory examination revealed loss of vibration and pressure sensation using a 10-g monofilament, consistent with diabetic peripheral neuropathy. Dorsalis pedis and posterior tibial pulses were palpable but reduced in volume. No clinical features of acute limb ischemia were noted.
Investigations
Baseline investigations showed poor glycemic control, with a fasting blood glucose of 216 mg/dL and HbA1c of 9.4%. White blood cell count was mildly elevated at 12,500/mm³, and C-reactive protein was raised. Renal and liver function tests were within acceptable limits.
Deep wound swab culture obtained under aseptic conditions revealed polymicrobial infection, with growth of methicillin-sensitive Staphylococcus aureus and Escherichia coli. Antimicrobial susceptibility testing demonstrated that both organisms were sensitive to beta-lactam antibiotics, including penicillins and cephalosporins, with no evidence of multidrug resistance. These findings supported the diagnosis of a moderate soft tissue infection and enabled targeted antibiotic therapy, facilitating effective infection control and contributing to favorable wound healing.
Plain radiography of the foot showed soft tissue swelling without evidence of osteomyelitis. Duplex Doppler ultrasound of the lower limbs demonstrated mild peripheral arterial disease with preserved distal flow. There was no critical limb ischemia.
Based on clinical and investigational findings, the condition was classified as a moderate infected diabetic foot ulcer (Wagner grade 2).
Based on the clinical presentation, neurological findings, microbiological results, and vascular assessment, a diagnosis of an infected diabetic foot ulcer secondary to diabetic peripheral neuropathy was established, with associated mild peripheral arterial disease contributing to impaired wound healing. The absence of critical limb ischemia and radiological evidence of osteomyelitis supported classification as a moderate soft tissue infection, guiding appropriate conservative and surgical management strategies.
The patient was managed by a multidisciplinary diabetic foot care team comprising a surgeon, endocrinologist, infectious disease specialist, podiatrist, and wound care nurse.
Initial management included hospital admission, strict glycemic control with insulin therapy, and empirical intravenous antibiotics, later tailored according to culture sensitivity. Surgical debridement was performed to remove necrotic tissue and reduce bacterial load.
Regular wound dressings with saline and antimicrobial agents were instituted, along with pressure offloading using customized footwear. The patient received intensive education on foot hygiene, daily inspection, and appropriate footwear use.
Over four weeks, the ulcer demonstrated progressive granulation and reduction in size. Antibiotics were transitioned to oral therapy, and the patient was discharged with close outpatient follow-up. At three-month review, the ulcer had completely healed, and the patient remained ambulatory with no recurrence. Glycemic control improved, with HbA1c reduced to 7.6%.
Diabetic foot ulcers are a leading cause of non-traumatic lower-limb amputations and reflect systemic disease severity rather than a localized problem alone. Peripheral neuropathy plays a central role by allowing repetitive unrecognized trauma, while infection accelerates tissue destruction and systemic complications [4].
This case underscores the importance of early identification of infection severity, assessment of vascular status, and prompt initiation of multidisciplinary care. Surgical debridement combined with appropriate antibiotics and metabolic optimization remains the cornerstone of treatment for infected DFUs [5].
Preventive strategies, including patient education, regular foot examinations, and early referral to specialized foot clinics, are critical in reducing disease burden. Long-term outcomes depend not only on wound healing but also on sustained glycemic control and lifestyle modification.
Diabetic foot disease remains a significant clinical challenge with substantial implications for patient quality of life and healthcare systems. This case highlights that timely diagnosis, structured evaluation, and coordinated multidisciplinary management can achieve limb salvage and favorable clinical outcomes. Prevention through patient education, routine screening, and optimal diabetes control remains the most effective strategy to reduce the incidence and recurrence of diabetic foot complications.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
2.
Prostate Cancer Treatment Associated With Long-Term Complications
3.
Unraveling the role of exercise in cancer suppression
4.
Parkinson patient's gait is restored by a spinal cord stimulator.
5.
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity
1.
The Unseen Danger of Anal Cancer: How to Protect Yourself
2.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
3.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
4.
HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management
5.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part VII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation